SYS-CON MEDIA Authors: Jason Bloomberg, Eric Brown, Bob Gourley, Sandi Mappic, RealWire News Distribution

News Feed Item

CPhI Korea Launches as South Korea Commits to Extensive Drug Development Over Next 5 Years

AMSTERDAM, February 27, 2014 /PRNewswire/ --

New event to accelerate and nurture South Korea's "Pharma 2020 Vision"

UBM Live has today announced the latest addition to its global pharmaceutical events portfolio, CPhI Korea 2014, which will take place on September 2nd-3rd 2014 at the COEX in Seoul, South Korea.

     (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

South Korea is now an undisputed member of the "developed pharmaceutical market" and home to the fastest growing industry within the developed 'league' according to IMS Health- which reported the Country's double digit growth rate over the last 5-years and predicted a CAGR of 6.5% until 2015. Furthermore, South Korea is ideally located to attract key delegates and industry leaders from Japan, China, India and Hong Kong. The event will act as a centralised hub for regional drug manufacturers to meet with global suppliers of raw materials, machinery, packaging solutions and contract services, as well as attracting visitors from the region looking for suppliers and manufacturing partners to bring cost-competitive pharmaceuticals to their individual markets.

The South Korean Government has affirmed its commitment to driving pharmaceutical R&D and innovations, with a clear "Pharma 2020 vision". By 2020, the country will have invested $8.9 billion into drug development, whilst setting out clear goals and projects including open innovation through enlargement of R&D and the collaboration of pharmaceuticals and finance to fund the extensive drug development plans.

CPhI Korea will be co-located with ICSE for contract services, providing an integrated platform for facilitating and encouraging the innovation and growth plans set out by the country. The two-day event will include a conference programme emphasising CPhI Korea's role in enabling international and domestic business.

Highlights of CPhI Korea 2014:

  • Co-location with ICSE providing services and opportunities through the whole supply chain
  • Conference programme featuring opinion leaders from Government, academia and industry- with workshops, round tables and plenary sessions
  • A buyers programme to deliver high-value buyers in growing markets
  • Potential one-to-one partnering for visitors and exhibitors to provide new leads and business partners

Chris Kilbee, Group Director, CPhI Pharma Portfolio, commented on the launch of the event: "CPhI Korea will provide an unrivalled opportunity for pharmaceutical industry delegates, stimulating key growth as the country strives to develop multiple drugs over the coming years. South Korea's commitment to R&D within the industry should be a benchmark model for other economies to follow, particularly as the healthcare landscape continues to rapidly change and healthcare demand is on the rise. The government support of R&D represents a remarkable growth opportunity and the launch of CPhI Korea will facilitate the innovations we are likely to witness as part of the country's 5-year plan.  CPhI Korea is launching at a boom time in the region and provides an unrivalled platform for domestic and international pharma companies to augment the next stage of development in this rapidly maturing and dynamic market".

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Korea, Southeast Asia, Istanbul, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also includes CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 at the Big Sight Exhibition Centre- Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 at the Lenexpo Exhibition Complex- St Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014 at the Jakarta International Expo- Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, at the Lutfi Kirdar Convention and Exhibition Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC- Shanghai, China); CPhI South America (5-7 August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI, ICSE Korea (2-3 September, 2014 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte- France); CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre- Mumbai).

About UBM Live

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis    
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: [email protected] / [email protected]

SOURCE UBM Live

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.